CUE EPS Estimates
Cue Biopharma, Inc.
$17.41
-$1.19(-6.40%)
51
Overall
60
Value
30
Tech
65
Quality
Market Cap
$135.12M
Volume
31.88K
52W Range
$4.97 - $45.50
Target Price
$81.02
CUE EPS estimates: the consensus estimate for Cue Biopharma, Inc.'s current fiscal year is -$21.79 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CUE EPS Estimates
- EPS estimate, current quarter
- $-4.04
- EPS estimate, next quarter
- $-2.83
- EPS estimate, current year
- $-21.79
- EPS estimate, next year
- $-8.70
- EPS growth, 3-year
- +81.57%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.28 |
| 2024 | $-21.60 |
| 2023 | $-33.30 |
| 2022 | $-44.70 |
| 2021 | $-42.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CUE | $17.41 | -6.4% | 31.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |